Preparation of double-loaded bitter ginseng derivative B21–DOX liposomes co-modified with SP94 and BR2 ligand and its in vitro anti-hepatocarcinogenic effect
SP94/BR2-B21/DOX-LP liposomes represent a promising targeted drug delivery system for hepatocellular carcinoma, offering improved membrane penetration, enhanced therapeutic efficacy, and reduced systemic toxicity.
Authors
- Jing Lin (ORCID: https://orcid.org/0000-0002-0203-7419)
- Mingqing Yuan (ORCID: https://orcid.org/0000-0002-1999-5509)
- Yonglong Zhong (ORCID: https://orcid.org/0000-0002-8327-9793)
- Lili Li (ORCID: https://orcid.org/0000-0002-0292-5889)
- Jiajia Zhang (ORCID: https://orcid.org/0000-0003-4623-6134)
- Xu Liu (ORCID: https://orcid.org/0000-0002-8932-4989)
- Simei Luo
- Zijun Tang
Institutions
- Guangxi University (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- Journal of Microencapsulation
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1080/02652048.2024.2390955
- Citations
- 1
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Natural Science Foundation of Guangxi Province